RecruitingNCT07222683

The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease


Sponsor

Brigham and Women's Hospital

Enrollment

80 participants

Start Date

Mar 10, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR). In CKD, ongoing inflammation and abnormal blood vessel growth can damage these small vessels, leading to heart stiffness and weaker heart function. A kidney transplant offers a unique chance to study how better kidney function and reduced inflammation affect heart health. The observational RESTORE study ("Impact of Renal Transplant on Coronary Microvascular Function in Patients with Advanced CKD") will measure heart blood flow and function before and after transplant. The study will test whether: 1. Inflammation and abnormal vessel growth are linked to poor heart blood flow and heart function in CKD. 2. Kidney transplant improves heart blood flow and function. 3. Lower inflammation after transplant leads to better heart health. By understanding how kidney disease and inflammation affect the heart-and how transplant may reverse these effects-this research could help guide future treatments to better protect heart health in patients with CKD.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether receiving a kidney transplant improves the tiny blood vessel function in the heart (coronary microvascular function) in patients with advanced chronic kidney disease. Poor kidney function is known to affect heart health, and this study tracks those changes around the time of transplant. **You may be eligible if...** - You are on the kidney transplant waitlist - You are 45 years or older, OR you are between 18 and 44 years old and have been on dialysis for 5 or more years **You may NOT be eligible if...** - Your heart's pumping function is severely reduced (ejection fraction below 40%) - You have had coronary artery bypass surgery (CABG) - You have had a heart transplant - You need a heart procedure (revascularization) identified during pre-transplant cardiac testing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Brigham and Women's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07222683


Related Trials